The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools, the NYGC serves as a nexus for collaboration in genomic research for the New York community and beyond.
While continuing efforts in our core activities, we are also now applying our expertise in genomics and our role as the scientific convener in New York to help accelerate and support COVID-19 genomics research. We believe the best chance of rapid progress will come through a network that pools together efforts and resources. In March 2020, NYGC Evnin Family Scientific Director and Chief Executive Officer Tom Maniatis, PhD, convened area researchers and other interested parties representing both our Institutional Founding Members and others, and the COVID-19 Genomics Research Network was launched.
The NYGC harnesses the expertise and builds on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners to advance genomic discovery. Central to our scientific mission is an outstanding faculty who are leading independent research labs based at the NYGC and jointly with one of our member institutions, bringing a multidisciplinary and in-depth approach to the field of genomics.
The NYGC has attracted leading scientists whose wide-ranging expertise — including single cell genomics, genome engineering, population genomics, statistical genetics, computational biology and bioengineering —brings a multidisciplinary and in-depth approach to the field of genomics. NYGC senior and core faculty members, who hold joint appointments at leading New York institutions, include a Nobel Laureate, three Lasker award winners and five members of the National Academy of Sciences. Since its inception, NYGC researchers have published more than 200 research studies in leading, high-impact scientific journals.